CTC, CELLSEARCH® El recuento de CTC de CELLSEARCH® demuestra su utilidad en cáncer de mama metastásico HR+ / HER2- 07.08.2025 - 18:05:38 Menarini Silicon Biosystems United States of America Canada France Germany Spain United Kingdom Italy View original content:https://www.prnewswire.com/news-releases/el-recuento-de-ctc-de-cellsearch-demuestra-su-utilidad-en-cancer-de-mama-metastasico-hrher2--302035046.html
